Last updated: 1 July 2024 at 6:33pm EST

Louise Francesconi Net Worth




The estimated Net Worth of Louise Francesconi is at least $1.63 Million dollars as of 28 June 2024. Ms. Francesconi owns over 4,737 units of Accelerate Diagnostics Inc stock worth over $54,028 and over the last 22 years she sold AXDX stock worth over $1,206,416. In addition, she makes $372,564 as Independent Director at Accelerate Diagnostics Inc.

Ms. Francesconi AXDX stock SEC Form 4 insiders trading

Louise has made over 30 trades of the Accelerate Diagnostics Inc stock since 2004, according to the Form 4 filled with the SEC. Most recently she exercised 4,737 units of AXDX stock worth $7,627 on 28 June 2024.

The largest trade she's ever made was exercising 75,949 units of Accelerate Diagnostics Inc stock on 31 May 2023 worth over $122,278. On average, Louise trades about 4,165 units every 107 days since 2003. As of 28 June 2024 she still owns at least 33,558 units of Accelerate Diagnostics Inc stock.

You can see the complete history of Ms. Francesconi stock trades at the bottom of the page.





Louise Francesconi biography

Louise L. Francesconi serves as Independent Director of the Company. Before retiring, Ms. Francesconi served as President of Raytheon Missile Systems, a defense electronics corporation, from 1997 to 2008. During her tenure at Raytheon, Ms. Francesconi was named three times by Fortune Magazine to its 50 Most Powerful Women in Business list. Ms. Francesconi currently serves as a director of US Energy Corporation and as Chairman of the Board of Trustees for Tucson Medical Center, a regional hospital. Ms. Francesconi has previously served as a director of Stryker Corporation, a medical technology company. Ms. Francesconi received a B.S. degree in Economics from Scripps College and an M.B.A. from the University of California, Los Angeles.

What is the salary of Louise Francesconi?

As the Independent Director of Accelerate Diagnostics Inc, the total compensation of Louise Francesconi at Accelerate Diagnostics Inc is $372,564. There are 5 executives at Accelerate Diagnostics Inc getting paid more, with John Phillips having the highest compensation of $12,300,900.



How old is Louise Francesconi?

Louise Francesconi is 67, she's been the Independent Director of Accelerate Diagnostics Inc since 2019. There are 4 older and 10 younger executives at Accelerate Diagnostics Inc. The oldest executive at Accelerate Diagnostics Inc is Jack Schuler, 79, who is the Independent Director.

What's Louise Francesconi's mailing address?

Louise's mailing address filed with the SEC is C/O ACCELERATE DIAGNOSTICS, INC., 3950 S. COUNTRY CLUB ROAD, SUITE 470, TUCSON, AZ, 85714.

Insiders trading at Accelerate Diagnostics Inc

Over the last 12 years, insiders at Accelerate Diagnostics Inc have traded over $26,833,308 worth of Accelerate Diagnostics Inc stock and bought 16,366,880 units worth $209,384,489 . The most active insiders traders include Jack W Schuler, Larry N Feinberg, and Matthew Strobeck. On average, Accelerate Diagnostics Inc executives and independent directors trade stock every 16 days with the average trade being worth of $132,645. The most recent stock trade was executed by Hany Massarany on 28 June 2024, trading 4,737 units of AXDX stock currently worth $7,627.



What does Accelerate Diagnostics Inc do?

accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.



Complete history of Ms. Francesconi stock trades at Accelerate Diagnostics Inc and Stryker

Insider
Trans.
Transaction
Total value
Louise Francesconi
Director
Option $5,542
28 Jun 2024
Louise Francesconi
Director
Option $11,604
29 May 2024
Louise Francesconi
Director
Buy $17,866
23 Jan 2024
Louise Francesconi
Director
Option $532,402
31 May 2023
Louise Francesconi
Director
Option $169,241
1 May 2020
Louise Francesconi
Director
Option $530,635
31 Jan 2020
Louise Francesconi
Director
Option $195,662
1 May 2019
Louise Francesconi
Director
Sale $501,643
25 Apr 2019
Louise Francesconi
Director
Option $519,750
31 Jan 2019
Louise Francesconi
Director
Option $118,606
21 Mar 2018
Louise Francesconi
Director
Option $501,720
1 Feb 2018
Louise Francesconi
Director
Option $121,128
21 Mar 2017
Louise Francesconi
Director
Sale $454,615
30 Jan 2017
Louise Francesconi
Director
Option $482,405
26 Jan 2017
Louise Francesconi
Director
Option $384,200
22 Apr 2016
Louise Francesconi
Director
Option $99,407
21 Mar 2016
Louise Francesconi
Director
Option $101,985
21 Mar 2015
Louise Francesconi
Director
Option $111,587
21 Mar 2014
Louise Francesconi
Director
Option $106,297
21 Mar 2013
Louise Francesconi
Director
Option $86,553
21 Mar 2012
Louise Francesconi
Director
Buy $192,000
28 Apr 2009
Louise Francesconi
Director
Buy $64,490
24 Jul 2008
Louise Francesconi
Director
Buy $128,940
23 Jul 2008
Louise Francesconi
Director
Buy $36,310
30 Nov 2007
Louise Francesconi
Director
Buy $35,045
26 Nov 2007
Louise Francesconi
Director
Buy $63,860
31 Jul 2007


Accelerate Diagnostics Inc executives and stock owners

Accelerate Diagnostics Inc executives and other stock owners filed with the SEC include: